These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29944166)

  • 1. Disfiguring Leukoderma Caused by Banned Cosmetics: A Quiz.
    Atzori L; Zanniello R; Sarais G; Piras V; Pilloni L; Zucca M; Brundu MA; Rongioletti F
    Acta Derm Venereol; 2018 Oct; 98(9):914-915. PubMed ID: 29944166
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical leukoderma due to hydroquinone: An unusual phenomenon.
    Das A; Ghosh A; Kumar P
    Indian J Dermatol Venereol Leprol; 2019; 85(5):567. PubMed ID: 30117459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progressive facial hyperpigmentation].
    Blumeyer A; Röwert-Huber J; Nast A; Reidel U
    Hautarzt; 2016 Nov; 67(11):922-924. PubMed ID: 27393085
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of chemical leucoderma with skin-lightening therapies.
    Odedra S; Yoo J
    Clin Exp Dermatol; 2021 Oct; 46(7):1391-1393. PubMed ID: 34263475
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Watanabe S; Tada Y
    Acta Derm Venereol; 2019 Nov; 99(12):1178-1179. PubMed ID: 31449314
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroquinone-induced depigmentation: case report and review of the literature.
    Jow T; Hantash BM
    Dermatitis; 2014; 25(1):e1-5. PubMed ID: 24407054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical-Induced Vitiligo.
    Harris JE
    Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
    J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of idiopathic vitiligo from contact leukoderma. Part II: Leukoderma due to cosmetics and bleaching creams.
    Fisher AA
    Cutis; 1994 May; 53(5):232-4. PubMed ID: 8039412
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhododendrol-induced leukoderma accompanied by allergic contact dermatitis caused by a non-rhododendrol skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
    Yagami A; Suzuki K; Sano A; Takahashi M; Kobayashi T; Morita Y; Ando A; Iwata Y; Matsunaga K
    J Dermatol; 2015 Jul; 42(7):739-40. PubMed ID: 25875673
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of possible chemical leukoderma secondary to usage of skin whitening agents.
    Cho M; Otsuka A; Irie H; Kataoka T; Kabashima K
    Eur J Dermatol; 2018 Oct; 28(5):701-702. PubMed ID: 30355541
    [No Abstract]   [Full Text] [Related]  

  • 12. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
    Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
    J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
    [No Abstract]   [Full Text] [Related]  

  • 13. The Quest for the Ultimate Skin-Lightening Agent.
    Hsieh S; Maranda EL; Salih T; Nguyen A; Jimenez J
    JAMA Dermatol; 2016 Apr; 152(4):372. PubMed ID: 27074355
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible allergic contact dermatitis with reticulate postinflammatory pigmentation caused by hydroquinone.
    Tatebayashi M; Oiso N; Wada T; Suzuki K; Matsunaga K; Kawada A
    J Dermatol; 2014 Jul; 41(7):669-70. PubMed ID: 24930690
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
    Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
    J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
    [No Abstract]   [Full Text] [Related]  

  • 16. The spectrophotometrical analysis of rhododendrol-induced leucoderma using a novel multispectral camera.
    Inoue M; Kikuchi K; Watabe A; Yamasaki K; Aiba S
    Br J Dermatol; 2016 Aug; 175(2):334-9. PubMed ID: 26991967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
    Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
    J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
    [No Abstract]   [Full Text] [Related]  

  • 18. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
    Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
    J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reasons for consulting related to skin-bleaching products used by 104 women in Brazzaville].
    Gathse A; Obengui ; Ibara JR
    Bull Soc Pathol Exot; 2005 Dec; 98(5):387-9. PubMed ID: 16425720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect profile of common components of skin-lightening cosmetics.
    Prescrire Int; 2011 Sep; 20(119):212-3. PubMed ID: 21954517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.